Peritoneoscintigraphy in detection of improper placement of peritoneal catheter into bowel lumen prior to chromic phosphate P-32 therapy. A case report

Janet Neutze, D. Van Nostrand, W. Major

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Radionuclide peritoneoscintigraphy has been used prior to chromic phosphate P-32 (P-32CP) intraperitoneal therapy to assure proper placement of the catheter in the peritoneal cavity, to exclude loculation, and to predict inadequate distribution of P-32CP. This is a case report of the detection of a peritoneal catheter improperly placed into the bowel lumen by pretherapy radionuclide peritoneoscintigraphy, and this case demonstrates the distinguishing characteristics of the radiocolloid distribution secondary to an intraluminal injection relative to an intraperitoneal injection.

Original languageEnglish (US)
Pages (from-to)777-779
Number of pages3
JournalClinical Nuclear Medicine
Volume10
Issue number11
DOIs
StatePublished - Jan 1 1985

Fingerprint

Radioisotopes
Catheters
Peritoneal Cavity
Intraperitoneal Injections
Injections
Therapeutics
chromic phosphate

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

@article{7117c29747d343b9ad98971c5ad78217,
title = "Peritoneoscintigraphy in detection of improper placement of peritoneal catheter into bowel lumen prior to chromic phosphate P-32 therapy. A case report",
abstract = "Radionuclide peritoneoscintigraphy has been used prior to chromic phosphate P-32 (P-32CP) intraperitoneal therapy to assure proper placement of the catheter in the peritoneal cavity, to exclude loculation, and to predict inadequate distribution of P-32CP. This is a case report of the detection of a peritoneal catheter improperly placed into the bowel lumen by pretherapy radionuclide peritoneoscintigraphy, and this case demonstrates the distinguishing characteristics of the radiocolloid distribution secondary to an intraluminal injection relative to an intraperitoneal injection.",
author = "Janet Neutze and {Van Nostrand}, D. and W. Major",
year = "1985",
month = "1",
day = "1",
doi = "10.1097/00003072-198511000-00005",
language = "English (US)",
volume = "10",
pages = "777--779",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

Peritoneoscintigraphy in detection of improper placement of peritoneal catheter into bowel lumen prior to chromic phosphate P-32 therapy. A case report. / Neutze, Janet; Van Nostrand, D.; Major, W.

In: Clinical Nuclear Medicine, Vol. 10, No. 11, 01.01.1985, p. 777-779.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Peritoneoscintigraphy in detection of improper placement of peritoneal catheter into bowel lumen prior to chromic phosphate P-32 therapy. A case report

AU - Neutze, Janet

AU - Van Nostrand, D.

AU - Major, W.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - Radionuclide peritoneoscintigraphy has been used prior to chromic phosphate P-32 (P-32CP) intraperitoneal therapy to assure proper placement of the catheter in the peritoneal cavity, to exclude loculation, and to predict inadequate distribution of P-32CP. This is a case report of the detection of a peritoneal catheter improperly placed into the bowel lumen by pretherapy radionuclide peritoneoscintigraphy, and this case demonstrates the distinguishing characteristics of the radiocolloid distribution secondary to an intraluminal injection relative to an intraperitoneal injection.

AB - Radionuclide peritoneoscintigraphy has been used prior to chromic phosphate P-32 (P-32CP) intraperitoneal therapy to assure proper placement of the catheter in the peritoneal cavity, to exclude loculation, and to predict inadequate distribution of P-32CP. This is a case report of the detection of a peritoneal catheter improperly placed into the bowel lumen by pretherapy radionuclide peritoneoscintigraphy, and this case demonstrates the distinguishing characteristics of the radiocolloid distribution secondary to an intraluminal injection relative to an intraperitoneal injection.

UR - http://www.scopus.com/inward/record.url?scp=0022361489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022361489&partnerID=8YFLogxK

U2 - 10.1097/00003072-198511000-00005

DO - 10.1097/00003072-198511000-00005

M3 - Article

C2 - 4075668

AN - SCOPUS:0022361489

VL - 10

SP - 777

EP - 779

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 11

ER -